These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 270098)

  • 1. [Treatment of acute leukemia].
    Jacquillat C; Weil M; Auclerc MF; Schaison G; Holland JF
    Nouv Rev Fr Hematol Blood Cells; 1977; 18(2):293-313. PubMed ID: 270098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results of treatment of acute luekemia in adults according to our records].
    Kotlarek-Haus S; Witkowska M; Kuliszkiewicz M
    Acta Haematol Pol; 1975; 6(1):51-8. PubMed ID: 1054903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy of acute leukemia. 4. Remission induction and remission maintenance therapy].
    Hirano M; Uetani T; Morita A; Sako F; Koie K
    Saishin Igaku; 1971 Oct; 26(10):2034-41. PubMed ID: 5288692
    [No Abstract]   [Full Text] [Related]  

  • 4. [Acute leukemia. Case material and therapeutic results].
    Paolino W; Resegotti L; Rossi M; Infelise V; Degani GF
    Minerva Med; 1975 May; 66(35):1642-52. PubMed ID: 1055305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of acute leukemias].
    Brilliant MD
    Ter Arkh; 1973 Sep; 45(9):72-85. PubMed ID: 4585646
    [No Abstract]   [Full Text] [Related]  

  • 6. L-asparaginase in treatment of acute leukemia in children.
    Misíková Z; Cáp J
    Neoplasma; 1978; 25(1):133-9. PubMed ID: 273152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: data from the trials ALL-BFM 86, 90, and 95.
    Möricke A; Zimmermann M; Reiter A; Gadner H; Odenwald E; Harbott J; Ludwig WD; Riehm H; Schrappe M
    Klin Padiatr; 2005; 217(6):310-20. PubMed ID: 16307416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of thioguanine on a combination of daunorubicine, cytarabine and prednisone in the treatment of acute leukaemia in adults. The Finnish Leukaemia Group.
    Scand J Haematol; 1979 Aug; 23(2):124-8. PubMed ID: 291122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Daunorubicin-prednisone in the treatment of acute nonlymphocytic leukemia.
    Peterson BA; Bloomfield CD; Theologides A; Kennedy BJ
    Cancer Treat Rep; 1981; 65 Suppl 4():29-33. PubMed ID: 6955011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Attempts at treatment of acute leukemia with L-asparaginase].
    Lawkowicz W; Krzemińska-Lawkowiczowa ; Kozlowska J; Polubiec A; Derulska D; Kolakowska-Polubiec K; Litwin J; Rokicka R
    Acta Haematol Pol; 1971; 2(4):305-10. PubMed ID: 5293225
    [No Abstract]   [Full Text] [Related]  

  • 11. The value of combination therapy in adult acute myeloid leukemia with central nervous system involvement.
    Castagnola C; Nozza A; Corso A; Bernasconi C
    Haematologica; 1997; 82(5):577-80. PubMed ID: 9407724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype.
    Bloomfield CD; Lawrence D; Byrd JC; Carroll A; Pettenati MJ; Tantravahi R; Patil SR; Davey FR; Berg DT; Schiffer CA; Arthur DC; Mayer RJ
    Cancer Res; 1998 Sep; 58(18):4173-9. PubMed ID: 9751631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical studies with rubidazone.
    Benjamin RS; Keating MJ; Swenerton KD; Legha S; McCredie KB
    Cancer Treat Rep; 1979 May; 63(5):925-9. PubMed ID: 287557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of rubidomycin in induction therapy with vincristine, prednisone, and L-asparaginase for standard risk childhood acute lymphocytic leukemia: results of a Dutch phase III study (ALL V). A report on behalf of the Dutch Childhood Leukemia Study Group (DCLSG).
    van der Does-van den Berg A; van Wering ER; Suciu S; Solbu G; van 't Veer MB; Rammeloo JA; de Koning J; van Zanen GE
    Am J Pediatr Hematol Oncol; 1989; 11(2):125-33. PubMed ID: 2665546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Importance of anthracyclines in infants in the treatment of acute lymphoblastic and non-lymphoblastic leukemias].
    Leverger G; Bancillon A; Schaison G
    Pathol Biol (Paris); 1987 Jan; 35(1):87-90. PubMed ID: 3550617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Liposomal daunorubicine combined with cytarabine in the treatment of relapsed/refractory acute myeloid leukemia in children].
    Reinhardt D; Hempel G; Fleischhack G; Schulz A; Boos J; Creutzig U
    Klin Padiatr; 2002; 214(4):188-94. PubMed ID: 12165900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The treatment of acute leukemia.
    Haskell CM; Cline MJ
    Ration Drug Ther; 1974 Oct; 8(10):1-7. PubMed ID: 4529560
    [No Abstract]   [Full Text] [Related]  

  • 18. [Childhood acute myeloblastic leukemias. Report of 21 cases].
    Laatiri MA; Chehata S; Amouri A; Bouaouina N; Chatti S; Saad A; Ennabli S
    Tunis Med; 2000 Mar; 78(3):167-71. PubMed ID: 11026819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current methods in the treatment of acute leukemias in pediatric age].
    Zuelzer WW; Ravindranath Y; Mastrangelo R
    Recenti Prog Med; 1975 Oct; 59(4):353-71. PubMed ID: 769105
    [No Abstract]   [Full Text] [Related]  

  • 20. Application of the study of prognostic factors to the treatment of childhood (less than 20 years old) acute lymphoblastic leukemia.
    Jacquillat C; Weil M; Auclerc MF; Schaison G; Chastang C; Harousseau JL; Bauters F; Olive D; Griscelli C; Bonnet M; Lamagnere JP; Bernard J
    Bull Cancer; 1980; 67(4):458-69. PubMed ID: 7013865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.